ANI Pharma (ANIP) Misses Q2 EPS by 16c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to ANI Pharma (ANIP) Misses Q2 EPS by 16c, Revenues Beat

ANI Pharmaceuticals Reports Second Quarter 2020 Results

August 6, 2020 6:50 AM EDT

- Second quarter 2020 net revenues of $48.5 million -

- Nikhil Lalwani named President and CEO, effective September 8, 2020

- Pharmaceutical industry executives, Jeanne Thoma and Tony Pera, join Board of Directors -

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2020.

Business and Recent Highlights:

Completed comprehensive gap assessment on lead product, Cortrophin®... More